top of page
DO YOU HAVE oGVHD?
We are now enrolling for Phase III.
ABOUT THE STUDY
This clinical trial is designed to test the effectiveness of a new eye drop treatment for individuals suffering from chronic ocular graft-versus-host disease (oGVHD). Ocular GVHD is a condition that can occur after a bone marrow or stem cell transplant, where the donated cells attack the recipient's eyes, leading to dryness and discomfort.
By participating in this study, individuals with oGVHD can access a potential new treatment at no cost, receive regular monitoring and care from experienced eye care professionals. This participation not only offers personal benefits but also contributes to medical research that may lead to improved treatments and better quality of life for those affected by oGVHD.
WHY PARTICIPATE
To learn more Call us at (727) 748-0420
bottom of page